Advertisement

Topics

AcelRx Pharmaceuticals shares soar on expectation of positive FDA vote on opioid painkiller Dsuvia

10:47 EDT 10 Oct 2018 | Proactive Investors

FDA briefing papers out today suggest that AcelRx has made sufficient changes to the painkiller to support its introduction in the market

Original Article: AcelRx Pharmaceuticals shares soar on expectation of positive FDA vote on opioid painkiller Dsuvia

NEXT ARTICLE

More From BioPortfolio on "AcelRx Pharmaceuticals shares soar on expectation of positive FDA vote on opioid painkiller Dsuvia"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...